| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $4.99 | $4.35 | $3.52 | $2.30 | $1.93 | $0.42 | $0.03 | $0.13 |
| EPS (Diluted) | $4.92 | $4.29 | $3.49 | $2.27 | $1.88 | $0.41 | $0.03 | $0.13 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.4B | $8.7B | $7.7B | $7.9B | $6.8B | $6.3B | $5.7B | $4.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.6B | $1.0B | $0.9B | $0.6B | $0.3B | $0.9B | $0.6B |
| Total Liabilities | $8.7B | $7.9B | $6.9B | $7.2B | $6.2B | $5.7B | $5.2B | $4.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.7B | $0.8B | $0.8B | $0.7B | $0.7B | $0.6B | $0.5B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $-0.5B | $-0.5B | $-0.2B |
| Investing Cash Flow | $-1.1B | $-1.5B | $0.4B | $-0.8B | $-0.3B | $-0.6B | $-0.2B | $0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $0.8B | $-0.5B | $1.0B | $0.5B | $0.5B | $1.1B | $-0.3B |